Korea Aerospace Industries (KAI) stock (047810.KS)
FA-50 and KF-21 jets, helicopters, airframe parts
No NYSE or Nasdaq listingAlso: KDEF
047810 · Korea Exchange · As of Nov 13, 2026 close, ₩1,350 per dollar
| Seoul ticker | 047810.KS |
|---|---|
| US listing | No NYSE or Nasdaq listing |
| Share price (close) | ₩104,200 (about $77) |
| Price date | Nov 13, 2026 |
| 1-year change | +1% |
| 52-week range | ₩97,300 – ₩202,000 |
| Market value | about $7.5B |
| Revenue, 12 months to Sep 2026 | $3.5B |
| Operating profit, same period | $201M (5.7% margin) |
| P/E, same period | 63.9x |
| P/B (Jun 30, 2026 book value) | 5.31x |
| Closest US peer | Lockheed Martin (LMT) |
What the company does
KAI is Korea's only maker of military aircraft. It builds the FA-50 light fighter, exported to Poland, the Philippines and Malaysia, and the new KF-21 fighter, which it began delivering to the Korean air force in September 2026.
It also supplies airframe parts to Boeing and Airbus. Backlog was ₩26.3 trillion at the end of September 2026, of which about ₩9.6 trillion is commercial airframe parts and ₩10.5 trillion is domestic programs. The state-owned Export-Import Bank of Korea is the largest shareholder.

Korea Aerospace Industries (KAI) vs. Lockheed Martin
Lockheed Martin (LMT): KAI's partner on the T-50 family. Latest quarter (Jul–Sep 2026): revenue about $20.7B, backlog $292B, P/E 21.4x.
What Korean analysts say
Tap a broker to read our summary of its report.
DS Investment & SecuritiesNov 4 · Buy₩186,000
“Confidence behind keeping the ₩10 trillion order target”
Third-quarter operating profit of ₩79.4 billion rose 31.9% and beat the ₩75.3 billion consensus, as a revaluation of expected costs lifted margins on aircraft export projects. New orders of ₩1.5 trillion included ₩1.4 trillion of undisclosed aircraft exports, leaving about ₩8 trillion to reach the ₩10 trillion annual order guidance. DS points to KF-21 exports, the third LAH helicopter production batch and another FA-50 deal as the remaining pipeline.
Eugene Investment & SecuritiesNov 4 · Buy₩146,000
“Everything has bottomed out”
Operating profit of ₩79.4 billion beat the ₩76 billion consensus, and the first two production KF-21 fighters, worth ₩212.9 billion, brought domestic margins back to normal. The quarter included ₩1.4527 trillion of aircraft export orders whose customer and model were not disclosed. Eugene expects about 60 aircraft deliveries in 2027 and about 90 in 2028.
iM SecuritiesNov 4 · Buy₩135,000▼ lowered
“3Q26: Are defense orders coming back?”
Revenue of ₩1.0643 trillion missed consensus by 10.5% while operating profit of ₩79.4 billion was roughly in line. An engine defect has held up LAH helicopter deliveries, with about 20 of this year's planned 30 likely to slip, and the company now sees revenue ₩400 billion to ₩500 billion below its ₩5.7 trillion guidance. iM cut its target by 10.6% after valuations of its benchmark peers Safran, Dassault and Saab fell.
Original report (Korean, PDF) · 12-month target
Summaries are ours, written from the brokers' Korean-language reports. Ratings and targets are the brokers' views, not ours, and targets are in won. Not investment advice.
For US investors
How to buy Korea Aerospace Industries (KAI) from the US
Related Korean stocks
- Hanwha Aerospace (012450.KS) · Defense
- Hyundai Rotem (064350.KS) · Defense
- LIG Defense & Aerospace (079550.KS) · Defense
- HD Hyundai Heavy Industries (329180.KS) · Shipbuilding
- Hanwha Ocean (042660.KS) · Shipbuilding
- Samsung Heavy Industries (010140.KS) · Shipbuilding
Related guides
Sources and notes
- No OTC symbol found on StockAnalysis.com (checked 2026.11.10)
- KDEF holdings: StockAnalysis.com (as of 2026.11.06)
- Backlog and segment results: company 3Q 2026 earnings releases
- Financials and share count: DART filings (2025 annual report, 1H 2025 and 1H 2026 reports)
Won converted at ₩1,350 per dollar. P/E and P/B use net profit and equity attributable to shareholders; preferred shares, where they exist, are counted with common shares.
For information only, not investment advice. See our full disclaimer.